摘要
背景:发现阿尔茨海默氏病(AD)和轻度认知功能障碍(MCI) 在出现症状前的早期迹象变得日益重要,使临床试验物有所值并从现有的治疗策略中获得最大受益。然而,区分MCI的早期迹象与正常认知老化是很困难的。生物学标记物广泛应用于AD病理过程的早期检测指标,但是评估这些生物标学志物是昂贵的,并且要广泛应用于症状出现前的社区居住老年人是富有挑战的。在此,我们提出评估社会学标志,它可能为识别引起AD和MCI的症状前期提供一种替代性或补充性以及从生态学观点来看的有效战略。方法:数据来自一个规模较大的随机对照临床试验(RCT),我们调查了使用远程视频通信软件进行日常对话互动是否能改善老年参与者的认知功能。我们评估参与者的话语在参与者和员工面谈者总话语中所占比例,并在干预试验中记录会话作为两人(参与者和面谈者) 在一对一谈话中相互交流的指标。我们检测认知功能正常者与MCI者之间话语比例是否不同。首先,运用广义估计方程分析话语比例结果,接着,运用逻辑回归模型分析认知状态结果,以此估计ROC曲线下面积(ROC-AUC)。结果:相对于那些认知功能正常者,MCI参与者在定时对话会话中的话语占总话语比例更高(p = 0.01)。控制了参与者的年龄、性别、面谈者和评估后这种差异仍然存在(p = 0.03)。当受试者所说的平均话语计数比例作为单变量计入模型时,逻辑回归模型分析显示识别MCI(较正常者)的ROC曲线下面积为0.71(95%置信区间:0.54 - 0.89)。结论:一个从生态学观点来看,如在自然对话中产生的口头语言的比例等有效社会学标志可能对从认知功能正常到MCI的转变敏感。
关键词: 生物学标志
Current Alzheimer Research
Title:Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech
Volume: 12 Issue: 6
Author(s): Hiroko H. Dodge, Nora Mattek, Mattie Gregor, Molly Bowman, Adriana Seelye, Oscar Ybarra, Meysam Asgari and Jeffrey A. Kaye
Affiliation:
关键词: 生物学标志
摘要: Background: Detecting early signs of Alzheimer’s disease (AD) and mild cognitive impairment (MCI) during the pre-symptomatic phase is becoming increasingly important for costeffective clinical trials and also for deriving maximum benefit from currently available treatment strategies. However, distinguishing early signs of MCI from normal cognitive aging is difficult. Biomarkers have been extensively examined as early indicators of the pathological process for AD, but assessing these biomarkers is expensive and challenging to apply widely among pre-symptomatic community dwelling older adults. Here we propose assessment of social markers, which could provide an alternative or complementary and ecologically valid strategy for identifying the pre-symptomatic phase leading to MCI and AD. Methods: The data came from a larger randomized controlled clinical trial (RCT), where we examined whether daily conversational interactions using remote video telecommunications software could improve cognitive functions of older adult participants. We assessed the proportion of words generated by participants out of total words produced by both participants and staff interviewers using transcribed conversations during the intervention trial as an indicator of how two people (participants and interviewers) interact with each other in one-on-one conversations. We examined whether the proportion differed between those with intact cognition and MCI, using first, generalized estimating equations with the proportion as outcome, and second, logistic regression models with cognitive status as outcome in order to estimate the area under ROC curve (ROC AUC). Results: Compared to those with normal cognitive function, MCI participants generated a greater proportion of words out of the total number of words during the timed conversation sessions (p=0.01). This difference remained after controlling for participant age, gender, interviewer and time of assessment (p=0.03). The logistic regression models showed the ROC AUC of identifying MCI (vs. normals) was 0.71 (95% Confidence Interval: 0.54 – 0.89) when average proportion of word counts spoken by subjects was included univariately into the model. Conclusion: An ecologically valid social marker such as the proportion of spoken words produced during spontaneous conversations may be sensitive to transitions from normal cognition to MCI.
Export Options
About this article
Cite this article as:
Hiroko H. Dodge, Nora Mattek, Mattie Gregor, Molly Bowman, Adriana Seelye, Oscar Ybarra, Meysam Asgari and Jeffrey A. Kaye , Social Markers of Mild Cognitive Impairment: Proportion of Word Counts in Free Conversational Speech, Current Alzheimer Research 2015; 12 (6) . https://dx.doi.org/10.2174/1567205012666150530201917
DOI https://dx.doi.org/10.2174/1567205012666150530201917 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases
Current Neuropharmacology Nanoparticles as Novel Carrier for Brain Delivery: A Review
Current Pharmaceutical Design Meta-Analysis of the Effectiveness and Safety of Prophylactic Use of Nimodipine in Patients with an Aneurysmal Subarachnoid Haemorrhage
CNS & Neurological Disorders - Drug Targets Fork Head Transcription Factors
Current Genomics Neonatal Brain Hemorrhage (NBH) of Prematurity: Translational Mechanisms of the Vascular-Neural Network
Current Medicinal Chemistry Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Evolution and Analysis of Heterogeneity in the Clinical Expression of Aortic Diseases Similar to Marfan’s Syndrome: Challenge and Art in Clinical Diagnosis
Current Rheumatology Reviews Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: From Vascular Spasm to Cortical Spreading Depolarizations
Current Neurovascular Research Cerebrospinal Fluid Proteins in the Diagnosis of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Case Series and Mini-Review on Elizabethkingia meningoseptica, A high Alert Organism Causing Meningitis in Premature Neonates from A Tertiary Care Hospital of Western Rajasthan
Infectious Disorders - Drug Targets Development of a Registry for Down Syndrome in the Gulf Area of the Middle East
Applied Clinical Research, Clinical Trials and Regulatory Affairs Analysis of Univariate and Multivariate Filters Towards the Early Detection of Dementia
Recent Advances in Computer Science and Communications Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Current Molecular Medicine Quantitative Gait Disturbances in Older Adults with Cognitive Impairments
Current Pharmaceutical Design Green Tea, A Medicinal Food with Promising Neurological Benefits
Current Neuropharmacology Newer Avenues for the Treatment of Leptomeningeal Carcinomatosis
Central Nervous System Agents in Medicinal Chemistry Aquaporins and Glia
Current Neuropharmacology The “Aged Garlic Extract” (AGE) and One of its Active Ingredients S-Allyl-LCysteine (SAC) as Potential Preventive and Therapeutic Agents for Alzheimer's Disease (AD)
Current Medicinal Chemistry Apo-E4 Allele in Conjunction with Aβ42 and Tau in CSF: Biomarker for Alzheimers Disease
Current Alzheimer Research